ResMed (NYSE:RMD) reported quarterly earnings of $2.81 per share which beat the analyst consensus estimate of $2.72 by 3.23 percent. This is a 15.64 percent increase over earnings of $2.43 per share from the same period last year. The company reported quarterly sales of $1.423 billion which beat the analyst consensus estimate of $1.396 billion by 1.90 percent. This is a 10.98 percent increase over sales of $1.282 billion the same period last year.